A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's MRNA, -2.27% COVID vaccine for children and adolescents aged 6 to 17.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,